Inflammation and coronary artery calcification in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study.

[1]  D. Berman,et al.  Coronary artery calcium as a predictor of coronary heart disease, cardiovascular disease, and all-cause mortality in Asian-Americans: The Coronary Artery Calcium Consortium. , 2019, Coronary artery disease.

[2]  F. Wilkinson,et al.  Suppression of SIRT1 in Diabetic Conditions Induces Osteogenic Differentiation of Human Vascular Smooth Muscle Cells via RUNX2 Signalling , 2019, Scientific Reports.

[3]  C. Daniel,et al.  Vascular Calcification in Chronic Kidney Disease: The Role of Inflammation , 2018, International journal of nephrology.

[4]  Janet S. Wright,et al.  Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool A Special Report From the American Heart Association and American College of Cardiology , 2017, Circulation.

[5]  Janet S. Wright,et al.  Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology. , 2017, Journal of the American College of Cardiology.

[6]  A. Khera,et al.  Sex-Based Differences in Cardiometabolic Biomarkers , 2017, Circulation.

[7]  Jon White,et al.  Role of Adiponectin in Coronary Heart Disease Risk , 2016, Circulation research.

[8]  Kiang Liu,et al.  Less Favorable Body Composition and Adipokines in South Asians Compared to Other U.S. Ethnic Groups: Results from the MASALA and MESA Studies , 2015, International Journal of Obesity.

[9]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[10]  M. Budoff,et al.  Comparing coronary artery calcium among U.S. South Asians with four racial/ethnic groups: the MASALA and MESA studies. , 2014, Atherosclerosis.

[11]  M. Budoff,et al.  Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study: Objectives, Methods, and Cohort Description , 2013, Clinical cardiology.

[12]  Zhimin Chen,et al.  Associations of Adiponectin and Leptin with Incident Coronary Heart Disease and Ischemic Stroke in African Americans: The Jackson Heart Study , 2013, Front. Public Health.

[13]  Judith S. Hochman,et al.  Reprint: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. , 2013, Journal of the American Pharmacists Association : JAPhA.

[14]  M. Valdés,et al.  La concentración sérica de adiponectina como biomarcador de calcificación arterial coronaria y lesiones coronarias graves , 2012 .

[15]  P. Libby.  Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[16]  D. Goff,et al.  Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. , 2012, JAMA.

[17]  J. J. Rivera,et al.  Differences in coronary plaque composition with aging measured by coronary computed tomography angiography. , 2012, International journal of cardiology.

[18]  M. Reilly,et al.  C‐Reactive Protein Modifies the Association of Plasma Leptin With Coronary Calcium in Asymptomatic Overweight Individuals , 2012, Obesity.

[19]  K. Toutouzas,et al.  Inflammatory markers and plaque morphology: an optical coherence tomography study. , 2012, International journal of cardiology.

[20]  J. J. Rivera,et al.  Association Between Obesity, High-Sensitivity C-Reactive Protein ≥2 mg/L, and Subclinical Atherosclerosis: Implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[21]  M. Bajaj,et al.  Adiponectin and vulnerable atherosclerotic plaques. , 2011, Journal of the American College of Cardiology.

[22]  P. Greenland,et al.  Coronary artery calcium score and risk classification for coronary heart disease prediction. , 2010, JAMA.

[23]  R. Detrano,et al.  Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis. , 2010, Atherosclerosis.

[24]  C. Bouchard,et al.  Sex differences in inflammatory markers: what is the contribution of visceral adiposity? , 2009, The American journal of clinical nutrition.

[25]  J. Danesh,et al.  Leptin and coronary heart disease: prospective study and systematic review. , 2009, Journal of the American College of Cardiology.

[26]  M. Reiser,et al.  Low Adiponectin Levels Are an Independent Predictor of Mixed and Non-Calcified Coronary Atherosclerotic Plaques , 2008, PloS one.

[27]  J. J. Rivera,et al.  Markers of inflammation and coronary artery calcification: a systematic review. , 2008, Atherosclerosis.

[28]  M. Kanematsu,et al.  Coronary artery calcification, arterial stiffness and renal insufficiency associate with serum levels of tumor necrosis factor-alpha in Japanese type 2 diabetic patients. , 2008, Diabetes research and clinical practice.

[29]  M. Reilly,et al.  Adipokines, insulin resistance, and coronary artery calcification. , 2008, Journal of the American College of Cardiology.

[30]  Moyses Szklo,et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.

[31]  Timur Shtatland,et al.  Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo , 2007, Circulation.

[32]  A. Go,et al.  Plasma leptin levels and coronary artery calcification in older adults. , 2007, The Journal of clinical endocrinology and metabolism.

[33]  Robert Wolk,et al.  Association between plasma adiponectin levels and unstable coronary syndromes. , 2007, European heart journal.

[34]  S. Yusuf,et al.  Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. , 2007, JAMA.

[35]  A. Khera,et al.  Relationship Between C-Reactive Protein and Subclinical Atherosclerosis: The Dallas Heart Study , 2005, Circulation.

[36]  T. Funahashi,et al.  [Adiponectin]. , 2020, Nihon rinsho. Japanese journal of clinical medicine.

[37]  A. Khera,et al.  Race and gender differences in C-reactive protein levels. , 2005, Journal of the American College of Cardiology.

[38]  H. Brenner,et al.  Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. , 2005, European heart journal.

[39]  P. Scherer,et al.  Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.

[40]  David M Maahs,et al.  Low Plasma Adiponectin Levels Predict Progression of Coronary Artery Calcification , 2005, Circulation.

[41]  E. Rimm,et al.  Adiponectin and future coronary heart disease events among men with type 2 diabetes. , 2005, Diabetes.

[42]  Jing Ma,et al.  Inflammatory markers and the risk of coronary heart disease in men and women. , 2004, The New England journal of medicine.

[43]  Bruce D. Johnson,et al.  Plasma leptin and prognosis in patients with established coronary atherosclerosis. , 2004, Journal of the American College of Cardiology.

[44]  A. Localio,et al.  Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[45]  Paul M. Ridker,et al.  Inflammation as a Cardiovascular Risk Factor , 2004, Circulation.

[46]  Cynthia J. Girman,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[47]  Nader Rifai,et al.  Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events , 2003, Circulation.

[48]  A. Localio,et al.  C-Reactive Protein and Coronary Artery Calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA) , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[49]  Nancy R Cook,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.

[50]  D. Levy,et al.  C-Reactive Protein Is Associated With Subclinical Epicardial Coronary Calcification in Men and Women: The Framingham Heart Study , 2002, Circulation.

[51]  N. Sattar,et al.  Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) , 2001, Circulation.

[52]  S. Yusuf,et al.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) , 2000, The Lancet.

[53]  M. Pfeffer,et al.  Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. , 2000, Circulation.

[54]  L. Hellström,et al.  Mechanisms behind gender differences in circulating leptin levels , 2000, Journal of internal medicine.

[55]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[56]  R. Balarajan,et al.  Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. , 1991, BMJ.

[57]  M. Lindberg,et al.  Adipose Tissue , 2018 .

[58]  M. Marmot,et al.  Mortality from coronary heart disease in Asian communities in London. , 1988, BMJ.

[59]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[60]  J. G. Murray,et al.  Blood Pressure , 1911, The Indian medical gazette.